Ginkgo Bioworks DNA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Concentration risk by Product | ||||||
| Agriculture | 13%— | —— | 29%+6.0pp | 23%-18.0pp | 41%+40.0pp | |
| Consumer and technology | 0%-3.0pp | 3%0.0pp | 3%+1.0pp | 2%+1.0pp | 1%— | |
| Food and nutrition | 7%— | —— | 3%-3.0pp | 6%+2.0pp | 4%— | |
| Government and defense | 35%+34.0pp | 1%-28.0pp | 29%+8.0pp | 21%+5.0pp | 16%— | |
| Industrial and environment | 7%— | —— | 3%-1.0pp | 4%-3.0pp | 7%— | |
| Pharmaceutical and biotechnology | 38%— | —— | 33%-11.0pp | 44%+13.0pp | 31%— | |
| Concentration risk by Geography | ||||||
| DENMARK | 13%— | —— | —— | —— | 11%— | |
| UNITED STATES | 66%— | —— | 76%+1.0pp | 75%-6.0pp | 81%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ginkgo Bioworks break its business down?
- Ginkgo Bioworks (DNA) reports concentration risk percentage by business across 2 parts — Biosecurity and Cell Engineering. Each is extracted from the segment footnotes and tracked over time.
- Where does Ginkgo Bioworks's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ginkgo Bioworks's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
